CANBERRA HEALTH SERVICES
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Employees
- -
- Market Cap
- -
Clinical Trials
16
Active:0
Completed:4
Trial Phases
2 Phases
Phase 2:3
Not Applicable:13
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Not Applicable
13 (81.3%)Phase 2
3 (18.8%)Dose Enhancement of Vancomycin IN Everyday Patients
- First Posted Date
- 2011-09-02
- Last Posted Date
- 2011-09-02
- Lead Sponsor
- The Canberra Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01427842
- Locations
- 🇦🇺
The Canberra Hospital, Canberra, Australian Capital Territory, Australia
Intravenous Saline Pre-hydration in Patients Undergoing Outpatient Colonoscopy
Phase 2
Completed
- Conditions
- Colonic Diseases
- Interventions
- Drug: Infusion of 1 litre of normal saline before colonoscopy
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- The Canberra Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT00308152
- Locations
- 🇦🇺
The Canberra Hospital, Garran, Australian Capital Territory, Australia
News
Australian Researchers Launch World-First Clinical Trial of PMR-116 to Target 'Undruggable' MYC-Driven Cancers
A world-first clinical trial targeting MYC-driven cancers will begin later this year, led by researchers from The Australian National University and funded by the Medical Research Future Fund.